BEAM STOCK ANALYSIS
Price summary
Last Close
34.79 $
Jul 2, 26
Market Cap
3.6 B $
Q1 2026 (TTM)
52-Week Range
Return and risk cards
Total Return
%+75.0
Volatility
%74.6
Sharpe Ratio
0.58
Sortino Ratio
0.69
Distance to Peak
%-2.1
Maximum Drawdown
-%38.2
Seasonality
Seasonality Chart
Periodic Returns
1M
+20.1%
3M
+41.1%
6M
+25.5%
YTD
+25.5%
1Y
+75.0%
3Y
+9.0%
Returns are computed from split-adjusted closes; dividends are not included.
YTD Return — Stock vs Asset Classes
Year-to-dateStock and gold/silver returns are in USD (metals converted into the stock's currency). The S&P 500 index is measured in its own currency.
Monthly positivity
Monthly Avg Positive/Negative Close
Frequently Asked Questions
What is the current Beam Therapeutics Inc (BEAM) stock price?
BEAM last closed at 34.79 $ (Jul 2, 26). Price data is refreshed after every trading day.
What is the market capitalization of Beam Therapeutics Inc?
Beam Therapeutics Inc (BEAM) has a market capitalization of approximately 3.6 B $ as of the latest reported period.
Who are the main competitors of BEAM?
Key peers of Beam Therapeutics Inc include TELIX Pharmaceuticals Ltd, Mesoblast Ltd, CSL Ltd. A detailed metric comparison is available on the Peers tab.
Go deeper on BEAM
Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.
